HYEX

distress 2/10 · well-funded / low risk

$0.91-15%today-73% from 52w high

healthyextractsinc.com22 employeesFounded 2014Henderson, NVDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$24M

Runway

—

Shares 1y

+0%

Price & events

-52.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

-14.6%

-34.2%

-66.1%

-41.0%

-52.9%

-44.6%

-71.2%

-91.9%

-87.7%

All

Overview

Market Cap: $15.44M
Volume: 323
52 Week Range: $0.84 – $3.35
Total Shares: 16.89M
Float Shares: 3.29M
% Held by Insiders: 80.53%
% Held by Institutions: 0.00%
RVOL: 0.60x
Beta: -0.78

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 16,890,868 · 0 offerings/1y · 3 PIPEs

2026-05-188-Kprivate_placement
2025-10-028-Kprivate_placement
2025-07-248-Kprivate_placement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified